首页|Advancing immunosuppression in liver transplantation:A narrative review
Advancing immunosuppression in liver transplantation:A narrative review
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
国家科技期刊平台
NETL
NSTL
万方数据
Immunosuppression is essential to ensure recipient and graft survivals after liver transplantation(LT).However,our understanding and management of the immune system remain suboptimal.Current im-munosuppressive therapy cannot selectively inhibit the graft-specific immune response and entails a sig-nificant risk of serious side effects,i.e.,among others,de novo cancers,infections,cardiovascular events,renal failure,metabolic syndrome,and late graft fibrosis,with progressive loss of graft function.Pharma-cological research,aimed to develop alternative immunosuppressive agents in LT,is behind other solid-organ transplantation subspecialties,and,therefore,the development of new compounds and strategies should get priority in LT.The research trajectories cover mechanisms to induce T-cell exhaustion,to in-hibit co-stimulation,to mitigate non-antigen-specific inflammatory response,and,lastly,to minimize the development and action of donor-specific antibodies.Moreover,while cellular modulation techniques are complex,active research is underway to foster the action of T-regulatory cells,to induce tolerogenic den-dritic cells,and to promote the function of B-regulatory cells.We herein discuss current lines of research in clinical immunosuppression,particularly focusing on possible applications in the LT setting.
国家科技期刊平台
NSTL
万方数据
